Skip to main content

Objektivierbarkeit klinischer Symptome und neuere Entwicklungen in Studien

  • Conference paper
Multiple Sklerose

Zusammenfassung

Die klinische Beurteilung bleibt auch im Zeitalter der hoch differenzierten paraklinischen Untersuchungsmethoden der goldene Standard, an dem sich Krankheitsverlauf und therapeutische Effekte messen müssen. Im Rahmen therapeutischer Studien, aber auch zunehmend in der Routinebetreuung von MS-Patienten ist es zur Gewährleistung einer einheitlichen Sprache immer wichtiger, zuverlässige Messinstrumente einzusetzen. Dabei ist gerade bei der Multiplen Sklerose klar, dass die exakte Erfassung, Beschreibung und Dokumentation der vielfältigen klinischen Erscheinungen dieser Erkrankung für Forscher und Kliniker eine noch ungelöste Herausforderung darstellt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Amato MP et al. (1988) Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis. Arch Neurol 45:746–748

    PubMed  CAS  Google Scholar 

  • Fog T (1965) A scoring system for neurological impairment in multiple sclerosis. Acta Neurol Scand 41 [Suppl 13]:551–555

    Google Scholar 

  • Francis DA et al. (1991) An assessment of disability rating scales in Multiple Sclerosis. Arch Neurol 48:299–301

    PubMed  CAS  Google Scholar 

  • Goodkin DE et al. (1988) Upper extremity function in multiple sclerosis: improving assessment sensitivity with box and block and nine-hole-peg-tests. Arch Phys Med Rehabil 69:850–854

    PubMed  CAS  Google Scholar 

  • Goodkin DE et al. (1992) Inter- und intrarater variability for grades 1.0–3.5 of the Kurtzke expanded disability status scale (EDSS). Neurology 42:859–863

    PubMed  CAS  Google Scholar 

  • Hauser SL et al. (1983) Intensive Immunosuppression in progressive multiple sclerosis. N Engl J Med 308:173–178

    Article  PubMed  CAS  Google Scholar 

  • Kappos L et al. (1988) Cyclosporine vs azathioprine in the long-term treatment of MS results of the German multicenter study. Ann Neurol 23:56–63

    Article  PubMed  CAS  Google Scholar 

  • Kappos L et al. (1999) Neurostatus-Training CD-ROM, point de rue, Basel

    Google Scholar 

  • Kurtzke JF (1983) Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33:1444–1452

    CAS  Google Scholar 

  • Lechner-Scott J et al. (1997) Expanded disability Status Scale (EDSS) Training for Multicenter Trials. J Neurol 244 [Suppl 3]:S25

    Google Scholar 

  • Noseworthy JH et al. (1990) Canadian Cooperative MS Study Group. Interrater variability with the expanded disability status scale (EDSS) and functional systems (FS) in a multi¬ple sclerosis clinical trial. Neurology 40:971–975

    PubMed  CAS  Google Scholar 

  • Patzold U et al. (1975) Vorschlag einer neurologischen Befunddokumentation mittels Mar- kierungsbeleg. Nervenarzt 46:550–556

    PubMed  CAS  Google Scholar 

  • Rudick R et al. (1996) Clinical outcomes assessment in multiple sclerosis. Ann Neurol 40:469–479

    Article  PubMed  CAS  Google Scholar 

  • Rudick R et al. (1997) Recommendations from the National Multiple Sclerosis Society Clini-cal Outcomes Assessment Task Force. Ann Neurol 42:379–382

    Article  PubMed  CAS  Google Scholar 

  • Rudick R et al. (2000) Predictive value of the Multiple Sclerosis Functional Composite in relapsing-remitting Multiple Sclerosis: results of a long-term follow-up study. Neurology 54 [Suppl 3]

    Google Scholar 

  • Sipe JC et al. (1988) A neurological rating scale (NRS) for use in multiple sclerosis. Neurol-ogy 34:1368–1372

    Google Scholar 

  • Tourtellotte WW et al. (1965) Quantitative clinical neurological testing. A study of a battery of tests designed to evaluate in part the neurological function of patients with multiple sclerosis and its use in a therapeutic trial. Ann NY Acad Sci 122:480–505

    CAS  Google Scholar 

  • Weinshenker BG et al. (1989) The natural history of multiple sclerosis: a geographically based study: I. clinical course and disability. Brain 112:133–146

    Article  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Lienert, C., Lechner-Scott, J., Kappos, L. (2001). Objektivierbarkeit klinischer Symptome und neuere Entwicklungen in Studien. In: Zettl, U.K., Mix, E. (eds) Multiple Sklerose. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59453-3_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59453-3_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-41121-5

  • Online ISBN: 978-3-642-59453-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics